|
The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday. ---------- Main Market small-cap winners ---------- Ondo InsurTech PLC, up 21% at 7.25p Imaging Biometrics Ltd, up 8.3% at 0.65p abrdn Property Income Trust Ltd, up 8.8% at 1.85p capAI PLC, up 7.1% at 0.60p Topps Tiles PLC, up 5.3% at 35.05p ---------- Main Market small-cap losers ---------- Headlam Group PLC, down 25% at 14.125p, reports lower interim revenue BSF Enterprise PLC, down 13% at 0.875p DeFi Development Corp UK PLC, down 13% at 17.50p Amigo Resources PLC, down 12% at 1.875p Cindrigo Holdings Ltd, down 11% at 4.25p ---------- AIM winners ---------- Ironveld PLC, up 34% at 0.03p, DMS plant now in ‘sustained production’, operating 16 hours per day Getech Group PLC, up 13% at 2.20p, expects higher interim revenue and Ebitda Mendell Helium PLC, up 11% at 4.10p Marechale Capital PLC, up 9.2% at 4.75p CelLBxHealth PLC, up 9.1% at 1.50p, sees higher revenue for 2026 ---------- AIM losers ---------- Angus Energy PLC, down 25% at 0.18p, shares restored to trading Poolbeg Pharma PLC, down 13% at 6.10p, raises £3.5 million in placing at 6p each Emmerson PLC, down 10% at 1.80p Jangada Mines PLC, down 9.8% at 0.925p Provexis PLC, down 9.6% at 1.22p ---------- Small-cap and AIM movers in focus: ---------- Headlam Group PLC, down 25% at 14.125 pence, 12-month range 14.07p-91.00p. Reports revenue for the six months to June 30 falls 23% to £188.8 million and says operating losses widen amid weak market conditions, product availability issues, competitor pressure and unseasonably warm weather. Net debt increases to £36.2 million from £31.4 million at the end of December, while the group launches a strategic review of funding options, including refinancing, property sales and new partnerships, to strengthen liquidity and support its turnaround. ---------- Ironveld PLC, up 34% at 0.03 pence, 12-month range 0.02p-0.08p. Says its DMS plant enters sustained production, operating 16 hours a day, with throughput expected to reach the 5-tonnes-per-hour design rate by the end of July. Adds three customers are secured, with repeat orders already received and products sold at projected premium prices, while identifying maghemite recovery as a potential new revenue stream. Separately, says initial results from its Layer 21 mineralogical study are expected within 30 days. ---------- Getech Group PLC, up 13% at 2.20 pence, 12-month range 1.67p-2.61p. Expects revenue for the six months to June 30 to rise 15% to £2.4 million and adjusted Ebitda to improve to £0.2 million from a loss a year earlier, citing stronger trading and the benefits of last year’s cost cuts. Says its order book increases to £4.0 million, cash triples to £0.6 million and a significantly expanded sales pipeline supports confidence in meeting full-year market expectations. ---------- CelLBxHealth PLC, up 9.1% at 1.50 pence, 12-month range 0.85p-2.80p. Reiterates confidence in delivering at least £2.1 million of revenue in financial 2026, up 50% from the prior year, saying its commercial opportunity remains unchanged despite last week’s management changes. Adds it has begun recruiting a new chief executive while Executive Chair Jan Groen says the company remains focused on converting its commercial pipeline into sustainable revenue growth. ---------- Poolbeg Pharma PLC, down 13% at 6.10 pence, 12-month range 2.50p-9.00p. Raises £3.5 million through a placing at 6.0p per share, with Executive Chair Cathal Friel subscribing for £250,000. Says the proceeds extend its cash runway into the second quarter of 2028 and will fund its POLB 001 topical and oral GLP-1 proof-of-concept trials while strengthening its position in ongoing partnering discussions. ---------- Copyright 2026 Alliance News Ltd. All Rights Reserved.
|
